You are here

Research

Drugmakers Pledge to Avoid Safety Shortcuts on Covid Vaccine - Bloomberg

USRS  NYRS  NCRRS  FLRSs   CARS
 
4 cover 
 
COVID-19  Vaccine Drug Safety
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

ANALYSIS: Coronavirus: Tests 'could be picking up dead virus'

The main test used to diagnose coronavirus is so sensitive it could be picking up fragments of dead virus from old infections, scientists say.

Most people are infectious only for about a week, but could test positive weeks afterwards.

Researchers say this could be leading to an over-estimate of the current scale of the pandemic.

But some experts say it is uncertain how a reliable test can be produced that doesn't risk missing cases.

Problem, Solution, SitRep, or ?: 

Covid-19 Live Updates: At-Home Virus Tests Remain ‘Aspirational’

As hope builds over possible frequent at-home testing, experts call the idea a long shot.

Over the past few weeks, a Harvard scientist has made headlines for a bold idea to curb the spread of the coronavirus: rolling out antigen tests, a decades-old underdog in testing technology, to tens of millions of Americans for near-daily, at-home use.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Medical Espionage: Race for Coronavirus Vaccine Pits Spy Against Spy

WASHINGTON — Chinese intelligence hackers were intent on stealing coronavirus vaccine data, so they looked for what they believed would be an easy target. Instead of simply going after pharmaceutical companies, they conducted digital reconnaissance on the University of North Carolina and other schools doing cutting-edge research.

Problem, Solution, SitRep, or ?: 

Pharma Companies Plan Joint Pledge on Vaccine Safety

A group of drug companies competing with one another to be among the first to develop coronavirus vaccines are planning to pledge early next week that they will not release any vaccines that do not follow rigorous efficacy and safety standards, according to representatives of three of the companies.

Problem, Solution, SitRep, or ?: 

Top Adviser To Operation Warp Speed Calls An October Vaccine 'Extremely Unlikely'

The Centers for Disease Control and Prevention is asking states to have a plan in place to distribute a COVID-19 vaccine as soon as late October — but that doesn't mean an effective treatment will be ready quite so soon.

In separate interviews Thursday with NPR, the chief scientific adviser to the Trump administration's vaccine development effort and the former director of the CDC's office of public health preparedness cautioned that an effective vaccine is likely still months away.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Research
howdy folks